Skip to main navigation Skip to search Skip to main content

Transfer: Combinations of Receptor-Targeted Alpha Radionuclide Therapy and Immune Checkpoint Inhibitors for Melanoma Treatment

Project: Research

Project Details

StatusActive
Effective start/end date04/1/26 → 03/31/27

Funding

  • National Cancer Institute: $2,750,463.21